* Cerus Corp CERS.OQ reported a quarterly adjusted loss
of 2
cents per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -3 cents. The mean expectation of six analysts for the
quarter was for a loss of 3 cents per share.
* Revenue rose 15.7% to $46.02 million from a year ago;
analysts
expected $47.34 million.
* Cerus Corp's reported EPS for the quarter was a loss of 2
cents.
* The company reported a quarterly loss of $2.93 million.
* Cerus Corp shares had fallen by 2.3% this quarter and
lost 21.3%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 5.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Cerus Corp is
$4.00
This summary was machine generated from LSEG data October 31 at
02:37 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.03 -0.02 Beat
Jun. 30 2024 -0.04 -0.03 Beat
Mar. 31 2024 -0.05 -0.05 Met
Dec. 31 2023 -0.02 -0.01 Beat